Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mindray Medical International Ltd (NYSE:MR)

Delayed Data
As of Nov 30
 -0.03 / -0.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 27.50, with a high estimate of 28.00 and a low estimate of 27.00. The median estimate represents a +2.54% increase from the last price of 26.82.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Mindray Medical International Ltd. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.26%
Growthannually -15.34%


Growthquarterly 27.17%
Growthannually 3.18%
Key to the earnings and sales forecast charts.